LPL Financial’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-35,173
| Closed | -$292K | – | 5240 |
|
|
2024
Q3 | $292K | Buy |
35,173
+8,759
| +33% | +$72.8K | ﹤0.01% | 4360 |
|
|
2024
Q2 | $189K | Buy |
26,414
+4,645
| +21% | +$33.3K | ﹤0.01% | 4491 |
|
|
2024
Q1 | $189K | Buy |
21,769
+593
| +3% | +$5.14K | ﹤0.01% | 4450 |
|
|
2023
Q4 | $139K | Sell |
21,176
-1,121
| -5% | -$7.34K | ﹤0.01% | 4421 |
|
|
2023
Q3 | $223K | Buy |
22,297
+1,145
| +5% | +$11.5K | ﹤0.01% | 4105 |
|
|
2023
Q2 | $263K | Buy |
21,152
+330
| +2% | +$4.1K | ﹤0.01% | 3913 |
|
|
2023
Q1 | $292K | Buy |
20,822
+7,899
| +61% | +$111K | ﹤0.01% | 3743 |
|
|
2022
Q4 | $185K | Buy |
12,923
+2,544
| +25% | +$36.4K | ﹤0.01% | 3994 |
|
|
2022
Q3 | $265K | Buy |
+10,379
| New | +$265K | ﹤0.01% | 3680 |
|
|
2022
Q1 | – | Sell |
-5,889
| Closed | -$247K | – | 4304 |
|
|
2021
Q4 | $247K | Sell |
5,889
-150
| -2% | -$6.29K | ﹤0.01% | 3825 |
|
|
2021
Q3 | $296K | Sell |
6,039
-921
| -13% | -$45.1K | ﹤0.01% | 3640 |
|
|
2021
Q2 | $290K | Buy |
+6,960
| New | +$290K | ﹤0.01% | 3601 |
|